Dr Abasi Ene-Obong is the founder and Chief Executive Officer of 54gene. He has extensive experience operating in the US, UK and Nigerian healthcare industries. Prior to 54gene, Dr Ene-Obong worked with leading healthcare organisations, including Fortune 100 pharmaceutical companies, academic and research institutions, and governments as a management consultant with PwC and IQVIA (formerly QuintilesIMS).
It is Dr Ene-Obong’s belief that African genetic data may hold the key to unlock untold medical
discoveries as African populations are proven to harbor the greatest genetic diversity in the world. In line with this, he founded 54gene; an African genomics company established to significantly improve the inclusion of African populations in global genomics research by building the world’s largest Pan-African biobank.
Dr Ene-Obong is uniquely qualified for the role as he holds a PhD in Cancer Biology from University of London, a Masters in human molecular genetics from Imperial College London and a Masters in Business Management from Claremont Colleges, California.
GapSummit is the premier, global, intergenerational biotechnology summit that attracts world leaders and the next generation of leaders to substantively discuss pressing challenges facing the bioeconomy and catalyze innovation to address these challenges.
GBR is a not-for-profit that connects biotech think-tanks, industrial leaders and research pioneers to young bio-leaders of tomorrow. GBR is solely led by young passionate and engaged researchers, students and professionals from across the world. GapSummit is GBR’s flagship event to advance its mission of developing and inspiring the next generation of leaders in the global bio-economy.